Ads
related to: psoriatic arthritis treatment- Before & After
See Results In Photos Of
Real Patients.
- About Psoriasis
Information On Plaque Psoriasis
& Options Available For Treatment.
- Therapy Information
Alternate Therapy For Plaque
Psoriasis.
- Patient Resources
Get Tools, Personalized Info,
Talk to a Nurse and More.
- About Plaque Psoriasis
Information On Plaque Psoriasis.
Learn About A Therapy Option.
- Co-Pay Program
Learn More and See If You Are
Eligible for a Co-Pay Card.
- Before & After
Search results
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 7 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
What To Know and Do About Jaw Pain on One Side
Health via Yahoo News· 2 days agoYou may also have discomfort in the neck, back, and stomach. Cancer: Oral cancer can cause one-sided jaw pain, difficulty moving your mouth, and swelling...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 7 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
Q2 2025 Earnings Estimate for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)
ETF DAILY NEWS· 5 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued on ...
High NSAID Use for axSpA May Not Raise Risk for Hypertension
Medscape· 1 day agoThere was no difference in the risk for hypertension between patients with axial spondylarthritis...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 3 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 3 days agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 6 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 5 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 6 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Ad
related to: psoriatic arthritis treatment